TLACPH Consulting ApS: Financial statements 2023
CVR: 40250360
Source: annual report 2023, Danish Business Authority
01/04/2022 – 31/03/2023
TLACPH Consulting ApS (CVR 40250360) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 175,894 and a net result of DKK 226,237 compared with DKK 890,422 the year before. That is a decrease of 81.5% compared with the year before. Equity in the 2023 report amounted to DKK 314,103. The solvency ratio was 78%.
- Gross Profit
- DKK 175,894
- Profit/Loss
- DKK 226,237
- Equity
- DKK 314,103
- Total Assets
- DKK 402,694
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 176 t. | 226 t. | 314 t. | - |
| 2022 | - | 950 t. | 890 t. | 2.5 mio. | - |
| 2021 | - | 2 mio. | 1.6 mio. | 1.6 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout TLACPH Consulting ApS
TLACPH Consulting ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named TLACPH Consulting IVS and Norse Therapeutics IVS. The management consists of Thomas Lars Andresen. The company is owned by TLA-HOLDING 2010 ApS. According to the 2024 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 35,979 and a net result of DKK 34,074 compared with DKK 53,389 the year before. Equity in the 2025 report amounted to DKK 151,566.